To hear about similar clinical trials, please enter your email below
Trial Title:
Enchasing Polyp Detection: The Effect of Adding Polyp Detection Attachment Device to Computer Aid Detection System.
NCT ID:
NCT06116864
Condition:
Colon Cancer Screening
Colon Cancer Surveillance
Conditions: Official terms:
Colonic Neoplasms
Conditions: Keywords:
Colon cancer screening
Colon cancer surveillance
Computer-Aided Detection of adenoma
Colonoscope attachment device
Endocuff
Study type:
Interventional
Study phase:
N/A
Overall status:
Enrolling by invitation
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Intervention model description:
This is a randomized controlled trial that compares Endocuff with Gi Genius (group A) to
GI Genius alone (group B) for patients who are undergoing elective outpatient
colonoscopy. Patients will be randomized by a secure online randomization software that
will allocate patients in a 1:1 ratio to group A or group B.
Primary purpose:
Screening
Masking:
Double (Participant, Outcomes Assessor)
Intervention:
Intervention type:
Device
Intervention name:
Endocuff and GI Genius
Description:
Endocuff is a polyp-detecting colonoscope attachment device. GI Genius is and
Computer-Aid Detection (CADe) system to detect polyps
Arm group label:
Endocuff + GI Genius
Intervention type:
Device
Intervention name:
GI Genius
Description:
GI Genius is and Computer-Aid Detection (CADe) system to detect polyps
Arm group label:
GI Genius
Summary:
Despite the widespread use of colonoscopy, the ongoing challenge of potentially missing
polyps remains. Previous studies have independently shown that both Endocuff, a
colonoscope attachment device for polyp detection, and Computer-Aided Detection (CADe)
systems have individually demonstrated enhanced lesion detection and safety. This study
seeks to evaluate the efficacy of combining the Endocuff CADe versus using CADe alone in
colonoscopy procedures for colorectal cancer screening and surveillance. This research
project aims to ascertain whether the synergistic application of these technologies
yields superior outcomes.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Age > 18
- Patients scheduled for an outpatient screening or surveillance colonoscopy.
Exclusion Criteria:
- Patients who require diagnostic colonoscopy (e.g.; anemia or GI bleeding).
- Patients requiring deep ileal intubation.
- Patients with inflammatory bowel disease.
- Patients with radiotherapy-induced colitis or other severe colitis.
- Patients with colonic strictures.
- Patients with acute diverticulitis.
- Patients with large bowel obstruction.
- Patients scheduled for therapeutic colonoscopy (e.g., planned endoscopic mucosal
resection for known polyps).
- Patients scheduled for assessment of a known colonic lesion.
- Patients with a known history of hereditary polyposis syndrome or untreated colon
cancer.
- Patients with a history of colon resection.
- Patients on continuous anti-thrombotic therapy
- Pregnancy.
- Patients who are ineligible for colonoscopy due to medical or psychiatric
conditions.
- Patients who are vulnerable or unable to consent
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
Marshall University Joan C. Edwards School of Medicine/Cabell Huntington Hospital
Address:
City:
Huntington
Zip:
25701
Country:
United States
Start date:
October 23, 2023
Completion date:
April 15, 2025
Lead sponsor:
Agency:
Marshall University
Agency class:
Other
Source:
Marshall University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06116864